BRUNO, WILLIAM
 Distribuzione geografica
Continente #
EU - Europa 8.658
AS - Asia 948
NA - Nord America 728
SA - Sud America 77
AF - Africa 14
OC - Oceania 1
Totale 10.426
Nazione #
IT - Italia 8.459
US - Stati Uniti d'America 690
SG - Singapore 376
CN - Cina 233
VN - Vietnam 178
BD - Bangladesh 73
FR - Francia 70
BR - Brasile 49
FI - Finlandia 37
DE - Germania 25
HK - Hong Kong 23
CA - Canada 22
JP - Giappone 21
AR - Argentina 15
GB - Regno Unito 12
CH - Svizzera 11
NL - Olanda 11
IN - India 8
MX - Messico 8
IQ - Iraq 6
RU - Federazione Russa 6
ID - Indonesia 4
LT - Lituania 4
SA - Arabia Saudita 4
AT - Austria 3
CZ - Repubblica Ceca 3
PL - Polonia 3
AZ - Azerbaigian 2
CL - Cile 2
DZ - Algeria 2
ES - Italia 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
UA - Ucraina 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MW - Malawi 1
NI - Nicaragua 1
NP - Nepal 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 10.426
Città #
Genova 4.074
Genoa 2.817
Rapallo 794
Vado Ligure 613
San Jose 192
Singapore 172
Ashburn 119
Council Bluffs 76
Lauterbourg 63
Beijing 50
Hanoi 50
Ho Chi Minh City 47
New York 38
Helsinki 34
Bordighera 27
Frankfurt am Main 21
Hong Kong 21
Milan 18
Tokyo 15
Rome 14
Los Angeles 11
Santa Clara 9
São Paulo 9
Zurich 8
Haiphong 7
Montreal 7
San Francisco 7
Tianjin 7
Buffalo 6
Amsterdam 5
Atlanta 5
Boardman 5
Bologna 5
Chicago 5
Da Nang 5
Mexico City 5
Baghdad 4
Biên Hòa 4
Can Tho 4
Houston 4
Land O' Lakes 4
London 4
Phoenix 4
Toronto 4
Vienna 4
Bari 3
Charlotte 3
Curitiba 3
Dallas 3
Lappeenranta 3
Marseille 3
Prague 3
Rio de Janeiro 3
Riyadh 3
Rudolfstetten 3
Warsaw 3
Addis Ababa 2
Asunción 2
Athens 2
Baku 2
Brantford 2
Brugherio 2
Buenos Aires 2
Bình Phước 2
Bắc Giang 2
Cagliari 2
Catania 2
Chennai 2
City of London 2
Denver 2
Des Moines 2
Fort Lauderdale 2
Gravina in Puglia 2
Guangzhou 2
Hải Dương 2
Kyiv 2
Lahore 2
Miami 2
Montes Claros 2
Mumbai 2
Nairobi 2
Naples 2
New Delhi 2
North Bergen 2
Orem 2
Padua 2
Pasadena 2
Piscataway 2
Quảng Ngãi 2
Quận Bình Thạnh 2
Riverside 2
San Pedro Sula 2
St Louis 2
Suzhou 2
Thái Nguyên 2
Tây Ninh 2
Ân Thi 2
Aachen 1
Acalanes Ridge 1
Alagoinhas 1
Totale 9.515
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 252
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 241
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 237
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 217
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 213
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 211
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 210
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 210
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 210
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 208
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 205
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 197
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT 197
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 196
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 193
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 191
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 186
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 186
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 183
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene 173
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 173
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 171
Identification, genetic testing, and management of hereditary melanoma 169
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 169
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 163
Communication of Clinically Useful Next-Generation Sequencing Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure? 162
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 162
A case of four synchronous cutaneous melanomas: Melanocortin 1 receptor polymorphisms and excessive sun exposure 159
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 157
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 156
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 155
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 153
Signs and genetics of rare cancer syndromes with gastroenterological features 153
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 153
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 153
Current State of Target Treatment in BRAF Mutated Melanoma 153
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 152
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 150
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 148
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 144
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 138
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 137
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 137
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. 137
Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation 134
Novel MC1R variants in Ligurian melanoma patients and controls 131
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. 128
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. 128
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations 127
Selection criteria for genetic assessment of patients with familial melanoma 122
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 115
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 111
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting 110
Novel MC1R variants and phenotypic expression of red hair in Ligurian melanoma patients and controls. 110
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families 104
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy 103
Skin examination behavior: The role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination 102
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 98
Melanoma risk factors, perceived threat and intentional tanning: An international online survey 97
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma 97
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 93
Multiple primary melanoma (MPM) as a valid criterion for genetic assessment : an Italian IMI multi-center study 89
Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing 85
Predictors of sun protection behaviors and severe sunburn in an international online study 81
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 80
Molecular Assessment in Patients with Melanoma: When and Why? 72
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 71
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 71
Definitions of genetic testing in Italian legal documents 71
Seven Synchronous Primary Melanomas on the Back 66
A Glance at Molecular Advances in Cancer Genetics: A Baffling Puzzle Still to Be Solved 63
Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges 52
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomes 47
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer 45
Special Issue “Molecular Advances in Cancer Genetics 3.0” 18
Totale 10.641
Categoria #
all - tutte 35.470
article - articoli 33.658
book - libri 0
conference - conferenze 1.490
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 322
Totale 70.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/2022760 24 43 62 78 35 63 48 165 54 72 32 84
2022/2023960 103 78 11 100 195 115 3 72 149 5 115 14
2023/2024580 21 54 8 70 33 105 35 51 35 22 39 107
2024/20251.613 36 101 61 130 188 159 181 284 61 90 131 191
2025/20263.244 323 113 542 232 372 236 407 128 270 308 269 44
Totale 10.641